EcoDrugPlus

Ensembl ID : ENSOMYG00000038750
Gene Symbol: -
1 Cross references
244 Possible Orthologues:

Ensembl ID : ENSOMYG00000045240
Gene Symbol: -
Cross references: -
311 Possible Orthologues:

Ensembl ID : ENSOMYG00000045801
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000045803
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000038381
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000045733
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSOMYG00000046842
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000047418
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000047493
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000047612
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Ensembl ID : ENSOMYG00000047735
Gene Symbol: -
1 Cross references
482 Possible Orthologues:

Ensembl ID : ENSOMYG00000047644
Gene Symbol: -
Cross references: -
173 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).